Riskpilot← Back to searchSign inGet full accessØRESUND RESEARCH ApS
APSActiveCVR 34076898Knud Højgaards Vej 9Engineering activities and related technical consultancy · NACE 7112Est. 2011— employees
Revenue 2024
DKK -15K
0% vs 2023
EBITDA margin
100.0%
0% vs 2023
Equity ratio
-81.5%
Financial strength
Net profit 2024
DKK -15K
-3% vs 2023
| Revenue | DKK -15K | +0% |
| EBITDA | DKK -15K | +0% |
| Net profit | DKK -15K | -3% |
| Total assets | DKK 6K | -82% |
| Equity | DKK -5K | -152% |
| Employees | — | — |
Legal name
ØRESUND RESEARCH ApS
CVR number
34076898
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
5. december 2011
Share capital
DKK 80.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er direkte og indirekte at handle med produkter og tjenester indenfor områderne - Research Informatics, Biotechnology, Pharmacology, Toxico informatics, Genomics, In-vitro an In-vivo screening, Life Sciences Technology consulting, Clinical data management services, Drug Pipeline databases, Annotation and Indexing of Chemical an Biological data, Biological an Chemical Databases, Medicinal Chemistry, Computational Chemistry Cheminformatics, Bioinformat- ics, R&D information systems, R&D data management, Drug Discovery and development services - og varer - og tjeneste-ydelser beslægtet hermed.
Address
Knud Højgaards Vej 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30 | 79 | 227 | -70 | 108 | -183 | -127 | -15 | -15 | -14 | -13 | -15 | -15 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 30 | 79 | 273 | -70 | 108 | -183 | -127 | -15 | -15 | -14 | -13 | -15 | -15 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 30 | 79 | 273 | -70 | 108 | -183 | -127 | -15 | -15 | -14 | -13 | -15 | -15 |
| Net financials | -1 | -12 | -23 | 36 | 9 | -11 | 1 | -0 | -1 | -0 | -1 | 0 | 0 |
| Profit before tax | 29 | 67 | 250 | -34 | 116 | -194 | -126 | -15 | -16 | -14 | -14 | -15 | -15 |
| Tax | 8 | 17 | 61 | -7 | 26 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 22 | 50 | 189 | -27 | 91 | -194 | -126 | -15 | -16 | -14 | -14 | -15 | -15 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 126 | 182 | 396 | 340 | 421 | 222 | 96 | 81 | 65 | 51 | 37 | 35 | 6 |
| Equity | 102 | 152 | 340 | 314 | 404 | 210 | 84 | 69 | 53 | 38 | 25 | 10 | -5 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 24 | 30 | 56 | 26 | 17 | 12 | 12 | 12 | 12 | 12 | 12 | 25 | 11 |
| Total debt | 24 | 30 | 56 | 26 | 17 | 12 | 12 | 12 | 12 | 12 | 12 | 25 | 11 |
EBITDA margin
-1509300.0%
This company
15.8%
Market median
-9552632% vs market
20122024
Equity ratio
-81.5%
This company
38.2%
Market median
-313% vs market
20122024
Return on equity
-1502200.0%
This company
18.4%
Market median
-8164230% vs market
20122024
Net profit margin
-1502200.0%
This company
8.1%
Market median
-18545779% vs market
20122024
Asset turnover
-2.40×
This company
1.12×
Market median
-314% vs market
20122024
Debt / equity
2.23×
This company
0.62×
Market median
-260% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2011-12-05 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JL Management | Management | 2025 | — | — |
TV Management | Management | 2011 | — | — |
AS Management | Management | 2015 | — | — |
HK Founder | Founder | 2011 | — | — |
AC Management | Management | 2012 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2025 | |
| Individual | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ØRESUND RESEARCH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| James Longden | Management | 0 companies |
| Tapan Vasudeo Apte | Management | 0 companies |
| Aniket Suresh Ausekar | Management | 0 companies |
| Ho Kei Au | Founder | 0 companies |
| Adarsh Chandra Nigam | Management | 0 companies |